Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 11 November 2008
Vol. 1, Issue 45, p. ec385
[DOI: 10.1126/scisignal.145ec385]


Immunology GSK-3β Masters TLR4 Responses

John F. Foley

Science Signaling, AAAS, Washington, DC 20005, USA

Stimulation of Toll-like receptor 4 (TLR4) by the bacterial product lipopolysaccharide (LPS) activates signaling pathways that are dependent and independent of the adaptor protein myeloid differentiation marker 88 (MyD88). MyD88-dependent signaling results in the production of proinflammatory cytokines, whereas MyD88-independent signaling, which involves the adaptor proteins TRAM and TRIF, results in the production of the type I interferon (IFN), IFN-β. Activation of TLR4 also triggers the phosphorylation [by phosphoinositide 3-kinase (PI3K)] and inactivation of glycogen synthase kinase-3β (GSK-3β), which modulates the types of cytokines produced in response to LPS through TLR4-MyD88 signaling. Wang et al. investigated the role of GSK-3β in MyD88-independent, TLR4-stimulated production of IFN-β. Stimulation of macrophages from MyD88-deficient mice with LPS resulted in a similar extent of phosphorylation of GSK-3β as was observed in macrophages from wild-type mice. LPS-stimulated macrophages in which GSK-3β was inhibited or depleted produced more IFN-β than did LPS-stimulated control macrophages, whereas expression of a constitutively active form of GSK-3β inhibited IFN-β production. The authors found that inhibition of GSK-3β resulted in the increased nuclear abundance of the transcription factor c-Jun, which is required for expression of the gene encoding IFN-β. In the context of depleted c-Jun, inhibition of GSK-3β activity did not increase the production of IFN-β in LPS-stimulated cells. Mice that received a GSK3 inhibitor before a sublethal dose of LPS produced more IFN-β than did LPS-treated control mice. Thus, GSK-3β appears to have an important role in modulating both MyD88-dependent and MyD88-independent responses to the TLR4 ligand LPS.

H. Wang, C. A. Garcia, K. Rehani, C. Cekic, P. Alard, D. F. Kinane, T. Mitchell, M. Martin, IFN-β production by TLR4-stimulated innate immune cells is negatively regulated by GSK3-β. J. Immunol. 181, 6797-6802 (2008). [PubMed]

Citation: J. F. Foley, GSK-3β Masters TLR4 Responses. Sci. Signal. 1, ec385 (2008).

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882